Lisapharma Acquired by Saixing: A New Chapter Begins

Chinese healthcare giant Saixing has successfully acquired Italian pharmaceutical company Lisapharma's business segment through a competitive public procedure as part of a concordato preventivo in continuità aziendale indiretta. Legal and advisory support played a crucial role in finalizing the deal. Chiomenti, an Italian law firm, advised Saixing with a team led by Giulia Battaglia. Lisapharma was supported by Bird & Bird for legal aspects, while Studio Bogoni handled financial and strategic counseling. The acquisition includes Lisapharma's production plant in Erba, machinery, patents, certifications, and inventory. Importantly, all 78 employees were retained, ensuring continued operational continuity and safeguarding human capital.